The copper-chelating agent, trientine, attenuates liver enzyme-altered preneoplastic lesions in rats by angiogenesis suppression

Oncology Reports

Volumn 10, Issue 5, 2003, Pages 1369-1373

  Yoshiji, Hitoshi ^a   Kuriyama, Shigeki ^b   Yoshii, Junichi ^a   Ikenaka, Yasuhide ^a   Noguchi, Ryuichi ^a   Yanase, Koji ^a   Namisaki, Tadashi ^a   Yamazaki, Masaharu ^a   Tsujinoue, Hirohisa ^a   Imazu, Hiroo ^a   Fukui, Hiroshi ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b KAGAWA UNIVERSITY   (Japan)

Author keywords

Angiogenesis; Carcinogenesis; Copper; Liver cancer; Trientine

Indexed keywords

ANGIOGENESIS INHIBITOR; CARCINOGEN; CD31 ANTIGEN; CHELATING AGENT; COPPER; CYCLINE; DIETHYLNITROSAMINE; GLUTATHIONE TRANSFERASE; MESSENGER RNA; TRIENTINE;

ANIMAL; ARTICLE; BIOSYNTHESIS; CELL DIVISION; CHEMICALLY INDUCED DISORDER; ENZYMOLOGY; FISCHER 344 RAT; IMMUNOHISTOCHEMISTRY; LIVER; LIVER TUMOR; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); POLYMERASE CHAIN REACTION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTIGENS, CD31; CARCINOGENS; CELL DIVISION; CHELATING AGENTS; COPPER; DIETHYLNITROSAMINE; GLUTATHIONE TRANSFERASE; IMMUNOHISTOCHEMISTRY; LIVER; LIVER NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; POLYMERASE CHAIN REACTION; PROLIFERATING CELL NUCLEAR ANTIGEN; RATS; RATS, INBRED F344; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRIETHYLENETETRAMINE;

EID: 2142802120     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.10.5.1369     Document Type: Article

References (29)

1. Carmeliet P and Jain RK: Angiogenesis in cancer and other diseases. Nature 407: 249-257, 2000.
2. Carmeliet P: Mechanisms of angiogenesis and arteriogenesis. Nat Med 6: 389-395, 2000.
3. Harris SR and Thorgeirsson UP: Tumor angiogenesis: biology and therapeutic prospects. In Vivo 12: 563-570, 1998. (Pubitemid 29011989)
4. Folkman J: Tumor angiogenesis: therapeutic implications. N Engl J Med 285: 1182-1186, 1971.
5. Li CY, Shan S, Huang Q, et al: Initial stages of tumor cell-induced angiogenesis: evaluation via skin window chambers in rodent models. J Natl Cancer Inst 92: 143-147, 2000. (Pubitemid 30089871)
6. Bergers G, Javaherian K, Lo KM, Folkman J and Hanahan D: Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. Science 284: 808-812, 1999. (Pubitemid 29291347)
7. Brandvold KA, Neiman P and Ruddell A: Angiogenesis is an early event in the generation of myc-induced lymphomas. Oncogene 19: 2780-2785, 2000. (Pubitemid 30339228)
8. Bolontrade MF, Stern MC, Binder RL, Zenklusen JC, Gimenez-Conti IB and Conti CJ: Angiogenesis is an early event in the development of chemically induced skin tumors. Carcinogenesis 19: 2107-2113, 1998. (Pubitemid 29010248)
9. Frachon S, Gouysse G, Dumorti J, et al: Endothelial cell marker expression in dysplastic lesions of the liver: an immunohistochemical study. J Hepatol 34: 850-857, 2001. (Pubitemid 32595184)
10. Befeler AS and Di Bisceglie AM: Hepatocellular carcinoma: diagnosis and treatment. Gastroenterology 122: 1609-1619, 2002. (Pubitemid 34533556)
11. Schafer DF and Sorrell MF: Hepatocellular carcinoma. Lancet 353: 1253-1257, 1999. (Pubitemid 29168472)
12. Llanos RM and Mercer JF: The molecular basis of copper homeostasis copper-related disorders. DNA Cell Biol 21: 259-270, 2002. (Pubitemid 34594540)
13. Hu GF: Copper stimulates proliferation of human endothelial cells under culture. J Cell Biochem 69: 326-335, 1998.
14. Raju KS, Alessandri G, Ziehe M and Gullino PM: Ceruloplasmin, copper ions, and angiogenesis. J Natl Cancer Inst 69: 1183-1188, 1982. (Pubitemid 13254912)
15. Sen CK, Khanna S, Venojarvi M, et al: Copper-induced vascular endothelial growth factor expression and wound healing. Am J Physiol Heart Circ Physiol 282: H1821-H1827, 2002. (Pubitemid 34654852)
16. Engleka KA and Maciag T: Inactivation of human fibroblast growth factor-1 (FGF-1) activity by interaction with copper ions involves FGF-1 dimer formation induced by copper-catalyzed oxidation. J Biol Chem 267: 11307-11315, 1992.
17. Yoshida D, Ikeda Y and Nakazawa S: Suppression of 9L gliosarcoma growth by copper depletion with copper-deficient diet and D-penicillamine. J Neurooncol 17: 91-97, 1993. (Pubitemid 24037966)
18. Brewer GJ: Copper control as an antiangiogenic anticancer therapy: lessons from treating Wilson's disease. Exp Biol Med (Maywood) 226: 665-673, 2001.
19. Ebara M, Fukuda H, Hatano R, et al: Relationship between copper, zinc and metallothionein in hepatocellular carcinoma and its surrounding liver parenchyma. J Hepatol 33: 415-422, 2000. (Pubitemid 30663379)
20. Yoshii J, Yoshiji H, Kuriyama S, et al: The copper-chelating agent, trientine, suppresses tumor development and angiogenesis in the murine hepatocellular carcinoma cells. Int J Cancer 94: 768-773, 2001. (Pubitemid 33032822)
21. Yoshiji H, Kuriyama S, Yoshii J, et al: Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats. Hepatology 34: 745-750, 2001. (Pubitemid 32927999)
22. Sone K, Maeda M, Wakabayashi K, et al: Inhibition of hereditary hepatitis and liver tumor development in Long-Evans cinnamon rats by the copper-chelating agent trientine dihydrochloride. Hepatology 23: 764-770, 1996.
23. Yoshiji H, Kuriyama S, Yoshii J, et al: Synergistic effect of basic fibroblast growth factor and vascular endothelial growth factor in murine hepatocellular carcinoma. Hepatology 35: 834-842, 2002. (Pubitemid 34258377)
24. Tanigawa N, Lu C, Mitsui T and Miura S: Quantitation of sinusoid-like vessels in hepatocellular carcinoma: its clinical and prognostic significance. Hepatology 26: 1216-1223, 1997. (Pubitemid 27509306)
25. Mazzanti R, Messerini L, Monsacchi L, et al: Chronic viral hepatitis induced by hepatitis C but not hepatitis B virus infection correlates with increased liver angiogenesis. Hepatology 25: 229-234, 1997. (Pubitemid 27015016)
26. Park YN, Kim YB, Yang KM and Park C: Increased expression of vascular endothelial growth factor and angiogenesis in the early stage of multistep hepatocarcinogenesis. Arch Pathol Lab Med 124: 1061-1065, 2000. (Pubitemid 30602050)
27. Brewer GJ, Dick RD, Grover DK, et al: Treatment of metastatic cancer with tetrathiomolybdate, an anticopper, antiangiogenic agent: phase I study. Clin Cancer Res 6: 1-10, 2000. (Pubitemid 30064969)
28. Pousset D, Piller V, Bureaud N and Piller F: High levels of ceruloplasmin in the serum of transgenic mice developing hepatocellular carcinoma. Eur J Biochem 268: 1491-1499, 2001. (Pubitemid 32231904)
29. Pitot HC and Dragan YP: Facts and theories concerning the mechanisms of carcinogenesis. FASEB J 5: 2280-2286, 1991. (Pubitemid 21892904)